[Treatment of hypertrophic obstructive cardiomyopathy with verapamil, a calcium antagonist (author's transl)]

Dtsch Med Wochenschr. 1976 Aug 27;101(35):1284-7. doi: 10.1055/s-0028-1104257.
[Article in German]

Abstract

Cardiac catheterisation with pressure measurements, left-ventricular cine-angiography and selective coronary angiography confirmed the diagnosis of hypertrophic obstructive cardiomyopathy in 20 patients. After a mean observation period of 20 months during which most of them were treated with beta-blockers, verapamil, 480 mg by mouth, was given for an average of 12 months. There was an impressive improvement in symptoms, compared with the state under beta-blocker treatment. There was a significant reduction in the ECG signs of left-ventricular hypertrophy and of the radiologically measured heart volume. Treatment of this condition with verapamil appeared to be superior to that with beta-blockers.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Calcium / antagonists & inhibitors*
  • Cardiac Volume
  • Cardiomyopathy, Hypertrophic / drug therapy*
  • Cardiomyopathy, Hypertrophic / physiopathology
  • Drug Evaluation
  • Electrocardiography
  • Female
  • Humans
  • Long-Term Care
  • Male
  • Middle Aged
  • Verapamil / therapeutic use*

Substances

  • Adrenergic beta-Antagonists
  • Verapamil
  • Calcium